Peptide Q&A #39 – The Full GH Peptide Breakdown, IGF-1 LR3 Protocols, with Paul Bakhtiar

Peptide Q&A #39 – The Full GH Peptide Breakdown, IGF-1 LR3 Protocols, with Paul Bakhtiar

April 30, 2026 · 1h 22m · Season 1 · Episode 91

About this episode

The episode features a detailed discussion on growth hormone peptides and IGF-1 LR3 protocols with expert Paul Bakhtiar.

Medical Disclaimer: We are not doctors. The content in this video is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Any compounds discussed may be intended for research purposes only. Use at your own risk. Welcome back, warriors! In this week's Peptide Q&A, JD Denham and William T. Haas sit down with returning guest Paul Bakhtiar president of telehealth for one of the largest peptide manufacturers in the country and keynote speaker at major peptide conferences for a deep dive into the entire growth hormone peptide category, IGF-1 LR3 protocols, how to stack without overlapping pathways, male fertility, and much more. Chapters: 00:00 – Intro to Peptides & Telehealth 06:01 – Growth Hormone Overview 11:50 – Timing & Dosing Peptides 18:04 – AOD 9604 & Fat Loss 25:55 – Optimizing GH & Bloodwork 30:23 – GH Peptides Breakdown (Tesa, CJC, Sermorelin) 35:40 – Peptide Blends & Side Effects 44:29 – HGH Risks, Legality & Hormones 51:21 – Slu-PP-332 & Fat Loss 54:11 – Fasting, Cancer & Healing (BPC-157) 1:01:41 – NAD+, Protocols & Final Takeaways We cover: • Mixing Multiple Peptides…

More episodes of Peptide of The Week

Explore listener stats, chart rankings, contacts and more on the Peptide of The Week podcast page.